GRAVITI FDA Wednesday, July 26, 2006 0.00 Neutral

FDA Approves Unknown Drug — GRAVITI PHARMS

Gravi Pharma announced that its generic drug has received FDA approval, a development expected to facilitate market entry and potentially generate revenue through competitive pricing against brand-name products.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day